ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is OPC Pharmaceutical JSC ?
1
High Management Efficiency with a high ROE of 15.33%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 53.82
3
The company has declared Negative results for the last 9 consecutive quarters
- INTEREST COVERAGE RATIO(Q) Lowest at 1,119.58
- INTEREST(Q) Highest at VND 4,004.61 MM
4
With ROE of 10.56%, it has a fair valuation with a 1.69 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -4.86%, its profits have fallen by -2.5%
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -4.86% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to OPC Pharmaceutical JSC should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is OPC Pharmaceutical JSC for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
OPC Pharmaceutical JSC
-2.51%
-0.31
26.01%
Vietnam VN Ho Chi Minh Index
38.87%
1.90
22.90%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.13%
EBIT Growth (5y)
-0.03%
EBIT to Interest (avg)
53.82
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
1.25
Tax Ratio
19.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.43%
ROE (avg)
15.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.64
EV to EBIT
8.55
EV to EBITDA
7.34
EV to Capital Employed
2.00
EV to Sales
1.06
PEG Ratio
2.96
Dividend Yield
NA
ROCE (Latest)
23.37%
ROE (Latest)
11.14%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 5.14% (YoY
Here's what is not working for OPC Pharmaceutical JSC
Raw Material Cost
Grown by 5.14% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
